Histone methylation keeps the brakes on autophagy by Collins, Patrick L & Oltz, Eugene M




Histone methylation keeps the brakes on
autophagy
Patrick L. Collins
Washington University School of Medicine in St. Louis
Eugene M. Oltz
Washington University School of Medicine in St. Louis
Follow this and additional works at: http://digitalcommons.wustl.edu/open_access_pubs
This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open
Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact engeszer@wustl.edu.
Recommended Citation
Collins, Patrick L. and Oltz, Eugene M., ,"Histone methylation keeps the brakes on autophagy." Molecular and Cellular Biology.33,20.
3974–3975. (2013).
http://digitalcommons.wustl.edu/open_access_pubs/3442
  Published Ahead of Print 26 August 2013. 
10.1128/MCB.01033-13. 
2013, 33(20):3974. DOI:Mol. Cell. Biol. 
Patrick L. Collins and Eugene M. Oltz
 
Autophagy
Histone Methylation Keeps the Brakes on
http://mcb.asm.org/content/33/20/3974




This article cites 17 articles, 8 of which can be accessed free at:
CONTENT ALERTS
 more»articles cite this article), 
Receive: RSS Feeds, eTOCs, free email alerts (when new
http://journals.asm.org/site/misc/reprints.xhtmlInformation about commercial reprint orders: 
http://journals.asm.org/site/subscriptions/To subscribe to to another ASM Journal go to: 
 o
n


















Histone Methylation Keeps the Brakes on Autophagy
Patrick L. Collins, Eugene M. Oltz
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA
Chromatin is organized into domains that are permissive orrepressive for transcription, depending largely on regional
patterns of covalent histone modifications. These epigenetic
marks recruit nuclear factors that regulate transcription either di-
rectly or via their actions to alter chromatin accessibility. For ex-
ample, dimethylation of histone-3 at lysine-9 (H3K9Me2) recruits
repressive chromatin modifiers and, accordingly, inhibits gene
transcription. Deposition of the H3K9me2 modification is medi-
ated by the histone methyltransferases (HMT) G9a (or KMT1C)
and GLP (or KMT1D) (1). These enzymes act predominantly in
euchromatin to coordinate repressive changes in gene expression
programs during cell fate decisions (2).
The importance of G9a/GLP in human health is underscored
by diseases that are linked to perturbations in this HMT complex.
For example, G9a activity participates in the resolution of inflam-
matory responses via its repression of proinflammatory cytokines
(3). Amplification of G9a is observed in diverse classes of tumors,
and in hepatocellular carcinomas, G9a knockdown inhibits their
continued growth (4). As such, HMT enzymes, including G9a/
GLP, are attractive targets for the design of small-molecule inhib-
itors that could reverse gene repression linked to pathogenesis. In
this regard, two groups have reported inhibitors, BRD4770 and
UNC0636, which have nanomolar affinity and exquisite specific-
ity for G9a/GLP, rendering them promising compounds for fu-
ture in vivo studies (5, 6).
In this issue ofMolecular and Cellular Biology, Artal-Martinez
de Narvajas et al. (7) report that treatment of tumor cell lines with
G9a inhibitors leads to the formation of autophagosome-like
structures, suggesting that G9a plays a role in regulating gene ex-
pression changes governing this cellular process.Macroautophagy
is used by nearly all cells to remove damaged organelles and extra-
neous proteins. Normally, cells in homeostasis inhibit autophagy
by the action of mammalian target of rapamycin complex 1
(mTORC1). However, upon experiencing starvation or other
types of stress, the same cells suppress mTORC1 kinase activity
and rapidly form autophagosomes (8). Initiation of macroau-
tophagy is thought to be transcription independent, because the
mTORC1 kinase directly represses the function of proteins in-
volved in autophagosome formation (Fig. 1, left). However,
recent studies have hinted that transcription-dependent steps
may drive macroautophagy following mTORC1-mediated ini-
tiation (9).
The study by Artal-Martinez de Narvajas et al. (7) now shows
that full engagement of the autophagy pathway is indeed tran-
scription dependent and requires relief of G9a repression at sev-
eral relevant genes. Specifically, the authors demonstrate that in
unstressed cells, G9a binds directly to the promoters of LC3B,
WIPI1, and DOR, whose products are required for the formation
of autophagosomes (10). In keeping with its role as a repressor,
RNA interference (RNAi)-mediated depletion of G9a enhances
H3K9 acetylation, polymerase II (Pol II) binding, and transcrip-
tion of these three genes while attenuating levels of the H3K9me2
repressive mark. Direct regulation of LC3B and WIPI1 is depen-
dent on the HMT function of G9a, since deletion of its enzymatic
SET domain reverses repression of these autophagy-associated
genes. Importantly, while G9a inhibition is sufficient to induce
autophagosome formation, it does not lead to their fusion with
lysosomes, which is required to complete the process known as
autophagic flux (11). Instead, inhibition of both G9a and
mTORC1 kinase activity is required to drive autophagy to com-
pletion.
Artal-Martinez de Narvajas et al. extend their findings to show
that G9a also restricts autophagy in primary cells, namely, human
CD4 T lymphocytes (7). Prior studies have shown that autopha-
gosomes form in these cells during T cell receptor (TCR)-medi-
ated proliferation (12). Indeed,mice rendered incapable of induc-
ing autophagy in this lineage exhibit impaired T cell proliferation
and survival (13). In their study, Artal-Martinez de Narvajas et al.
used TCR agonists and starvation each to induce autophagy in
CD4 cells and demonstrated that sustained expression of LC3B,
DOR, andWIPI1 again requires expulsion of G9a from their pro-
moters (7). While prior studies have shown that G9a is dispens-
able for lymphocyte development, this HMT is necessary for dif-
ferentiation of mature T cells into distinct functional lineages
(14). However, the connections between proliferation-induced
autophagy and differentiation into functional T cell subsets dur-
ing an immune response remain to be established.
Overall, this study establishes a new regulatory pathway that
represses the initial stages of autophagy (7). Reversal of G9a-me-
diated transcriptional repression, in conjunction with mTORC1
inhibition, drives autophagy, recovering nutrients that maintain
viability during cellular stress and proliferative bursts. In addition,
Artal-Martinez de Narvajas et al. (7) provide numerous avenues
for future studies. For example, the mechanisms by which G9a is
removed or displaced from promoters at autophagosome genes as
well its relationship to other chromatin modifiers, such as the
autophagy-associated histone acetyltransferase hMOF (15), re-
main to be determined. To date, at least two transcription factors,
TFEB and JunB, have been implicated in the regulation of au-
tophagy (9, 16). As Atral-Martinez de Narvajas et al. suggest the
leading candidate for links to G9a repression of autophagy in T
lymphocytes is JunB, which is a component of signaling pathways
downstreamof TCR activation. Another interesting possibility for
future exploration is a role for G9a in autophagy that is indepen-
dent of its function in histonemodification. Perhaps the G9a/GLP
Published ahead of print 26 August 2013
Address correspondence to Eugene M. Oltz, eoltz@wustl.edu.
Copyright © 2013, American Society for Microbiology. All Rights Reserved.
doi:10.1128/MCB.01033-13
The views expressed in this Commentary do not necessarily reflect the views of the
journal or of ASM.
COMMENTARY
3974 mcb.asm.org Molecular and Cellular Biology p. 3974–3975 October 2013 Volume 33 Number 20
 o
n








complex methylates directly lysines on proteins involved in au-
tophagosome formation.
Finally, the study described here (7) should stimulate further
exploration of the therapeutic potential for this G9a-mediated re-
pressionpathway. Indeed, perturbations of autophagy have been im-
plicated in cancer, neurodegeneration, autoimmunity, and thedevel-
opment of diabetes (8). The therapeutic potential of G9a inhibitors
for reversal of these pathogenic processes was bolstered by a recent
study showing that BRD4770 can synergize with other inducers of
autophagy to block the growth of pancreatic cancer cells in vitro (17).
Together, G9a, mTORC1, and autophagy stand at the crossroads of
molecular targets for inhibitors that could ultimately find clinical ap-
plications for the treatment of multiple pathologies.
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FIG 1 Repression of autophagosome formation by G9a. Under resting, nutrient-rich conditions (left), G9a represses autophagosome genes LC3B, DOR, and
WIPI1 by modifying the chromatin around gene promoters with the repressive H3K9me2 mark. In the cytoplasm, mTORC1 kinase phosphorylates and
inactivates complexes containing ULK1 that drive autophagosome formation. Upon starvation or during T cell proliferation (right), G9a and H3K9me2 are
removed from relevant promoters, leading to expression of LCB3, DOR, and WIPI1, which are essential components of autophagosomes. This transcription-
dependent process synergizes with inactivation of mTORC1, which releases restrictions on ULK1 complexes and guides autophagic flux to its completion.
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